STO 125 (Carbidopa, entacapone and levodopa 31.25 mg / 200 mg / 125 mg)
Pill imprint STO 125 has been identified as Carbidopa, entacapone and levodopa 31.25 mg / 200 mg / 125 mg.
Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 31.25 mg / 200 mg / 125 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about carbidopa/entacapone/levodopa
- Carbidopa, entacapone, and levodopa
- Carbidopa, entacapone, and levodopa (Advanced Reading)
Related treatment guides
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.